1.29
price down icon12.35%   -0.1817
after-market After Hours: 1.29
loading
Virax Biolabs Group Ltd stock is traded at $1.29, with a volume of 326.82K. It is down -12.35% in the last 24 hours and down -31.38% over the past month. Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
See More
Previous Close:
$1.4717
Open:
$1.4665
24h Volume:
326.82K
Relative Volume:
0.93
Market Cap:
$5.60M
Revenue:
$79,300
Net Income/Loss:
$-6.92M
P/E Ratio:
-0.068
EPS:
-18.9818
Net Cash Flow:
$-5.34M
1W Performance:
-5.15%
1M Performance:
-31.38%
6M Performance:
-50.19%
1Y Performance:
+51.76%
1-Day Range:
Value
$1.26
$1.58
1-Week Range:
Value
$1.26
$1.58
52-Week Range:
Value
$0.60
$8.9999

Virax Biolabs Group Ltd Stock (VRAX) Company Profile

Name
Name
Virax Biolabs Group Ltd
Name
Phone
-
Name
Address
-
Name
Employee
17
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
VRAX's Discussions on Twitter

Compare VRAX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VRAX
Virax Biolabs Group Ltd
1.29 5.60M 79,300 -6.92M -5.34M -18.98
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
502.92 129.14B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
680.61 74.41B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
581.21 35.31B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
241.75 31.30B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
254.57 27.35B 3.32B -860.46M -1.04B -8.32

Virax Biolabs Group Ltd Stock (VRAX) Latest News

pulisher
08:29 AM

Virax Biolabs Highlights T-Cell Dysfunction in Post-Infection Syndromes - TipRanks

08:29 AM
pulisher
08:25 AM

Virax Biolabs shares T-Cell dysfunction findings - Investing.com India

08:25 AM
pulisher
07:30 AM

Virax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation Meeting - Yahoo Finance

07:30 AM
pulisher
Mar 05, 2025

Virax Biolabs to Present at World Immune Regulation Meeting - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

Can Virax's T-Cell Research at WIRM 2025 Advance Post-Infection Syndrome Treatment? - StockTitan

Mar 05, 2025
pulisher
Feb 28, 2025

Cosmos Health expands distribution of Avian Influenza kits - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Short Interest in Virax Biolabs Group Limited (NASDAQ:VRAX) Expands By 205.8% - Defense World

Feb 28, 2025
pulisher
Feb 25, 2025

Virax Biolabs aligns with US vaccine transparency efforts By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Virax Biolabs Aligns with US Health Department on Vaccine Transparency - TipRanks

Feb 25, 2025
pulisher
Feb 25, 2025

How Virax's Vaccine Testing Tech Could Capitalize on New Government Transparency Push - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency - Benzinga

Feb 25, 2025
pulisher
Feb 20, 2025

Contrasting Virax Biolabs Group (NASDAQ:VRAX) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World

Feb 20, 2025
pulisher
Feb 10, 2025

Market Watch: Virax Biolabs Group Ltd (VRAX)’s Noteworthy Drop, Closing at 1.71 - The Dwinnex

Feb 10, 2025
pulisher
Feb 02, 2025

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 33.9% in January - Armenian Reporter

Feb 02, 2025
pulisher
Jan 23, 2025

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait - Yahoo Finance

Jan 23, 2025
pulisher
Jan 14, 2025

Cosmos Health secures exclusive distribution agreement with Virax Biolabs - Yahoo Finance

Jan 14, 2025
pulisher
Jan 13, 2025

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries - Lelezard

Jan 13, 2025
pulisher
Jan 09, 2025

Virax Biolabs Group Ltd (VRAX) Forecast: Revisiting The Past To Gain Insights For The Future - Stocks Register

Jan 09, 2025
pulisher
Jan 07, 2025

Virax Biolabs stock soars 45% on Mpox detection kit deal: What you need to know - MSN

Jan 07, 2025
pulisher
Dec 27, 2024

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 38.5% in December - Defense World

Dec 27, 2024
pulisher
Dec 23, 2024

Virax Biolabs Achieves Shareholder Approvals at Adjourned Annual Meeting - TipRanks

Dec 23, 2024
pulisher
Dec 21, 2024

Stock Region Signal Report - substack.com

Dec 21, 2024
pulisher
Dec 19, 2024

Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket - Benzinga

Dec 19, 2024
pulisher
Dec 17, 2024

Virax Biolabs Announces Strategic Goals and Developments for 2025 - TipRanks

Dec 17, 2024
pulisher
Dec 17, 2024

Virax Biolabs Advances T-Cell Platform with $7.3M War Chest, Expands European Distribution Network - StockTitan

Dec 17, 2024
pulisher
Dec 11, 2024

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect across the European Union, Norway, and Switzerland - Marketscreener.com

Dec 11, 2024
pulisher
Dec 10, 2024

Virax Biolabs Expands ImmuneSelect Reach in Europe - TipRanks

Dec 10, 2024
pulisher
Dec 10, 2024

Virax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and Switzerland - Yahoo Finance

Dec 10, 2024
pulisher
Nov 27, 2024

Virax Biolabs Group First Half 2025 Earnings: US$0.89 loss per share (vs US$1.64 loss in 1H 2024) - Simply Wall St

Nov 27, 2024
pulisher
Nov 20, 2024

Virax Biolabs Sees Asset Growth Amid Financial Loss - TipRanks

Nov 20, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Virax Biolabs Group Ltd - GuruFocus.com

Nov 15, 2024
pulisher
Nov 01, 2024

Virax Biolabs announces 2024 annual meeting - Investing.com India

Nov 01, 2024
pulisher
Oct 31, 2024

Virax Biolabs announces 2024 annual meeting By Investing.com - Investing.com UK

Oct 31, 2024
pulisher
Oct 31, 2024

Virax Biolabs Sets Date for 2024 AGM - TipRanks

Oct 31, 2024
pulisher
Oct 23, 2024

Virax Biolabs announces distribution agreement with Europa Biosite - TipRanks

Oct 23, 2024
pulisher
Oct 23, 2024

Virax Biolabs Expands Reach with Europa Biosite Deal - TipRanks

Oct 23, 2024
pulisher
Oct 23, 2024

EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland - Yahoo Finance

Oct 23, 2024
pulisher
Oct 23, 2024

Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland - StockTitan

Oct 23, 2024
pulisher
Oct 04, 2024

Pre-market Movers: ALZN, VRAX, APDN, LQDA... - RTTNews

Oct 04, 2024
pulisher
Oct 03, 2024

Analyzing the Impact of Earnings Reports on Virax Biolabs Group Ltd Inc. (VRAX) Price Performance - The InvestChronicle

Oct 03, 2024
pulisher
Oct 03, 2024

Daily Progress: Virax Biolabs Group Ltd (VRAX) Gain 14.20, Closing at 1.85 - The Dwinnex

Oct 03, 2024
pulisher
Sep 30, 2024

Virax Biolabs Plans New Share Offering - TipRanks

Sep 30, 2024
pulisher
Sep 27, 2024

Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session - MSN

Sep 27, 2024
pulisher
Sep 25, 2024

Virax Biolabs Group Limited (NASDAQ:VRAX) Short Interest Down 72.2% in September - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Charting the Course: Virax Biolabs Group Ltd’s VRAX Stock Prospects - The InvestChronicle

Sep 25, 2024
pulisher
Sep 23, 2024

How did Virax Biolabs Group Ltd (VRAX) fare last session? - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Daily Market Movement: Virax Biolabs Group Ltd (VRAX) Sees a -3.56 Decrease, Closing at 2.44 - The Dwinnex

Sep 23, 2024
pulisher
Sep 17, 2024

Virax Biolabs Group Ltd (VRAX)’s Day in Review: Closing at 2.84, Up by 9.65 - The Dwinnex

Sep 17, 2024

Virax Biolabs Group Ltd Stock (VRAX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$75.07
price up icon 1.39%
$305.39
price down icon 0.55%
$19.19
price down icon 3.62%
$32.68
price down icon 0.52%
$97.47
price down icon 2.84%
biotechnology ONC
$254.57
price up icon 1.89%
Cap:     |  Volume (24h):